Development of murine plasmacytoid dendritic cell subsets

Immunology and Cell Biology

Volumn 83, Issue 5, 2005, Pages 563-570

  Naik, Shalin H ^a,b   Corcoran, Lynn M ^a   Wu, Li ^a  

^a Department of Civil and Environmental Engineering   (Australia)

^b WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

Dendritic cell; Development; Haematopoiesis; Plasmacytoid

Indexed keywords

CYTOKINE; TRANSCRIPTION FACTOR;

BONE MARROW CELL; CELL LINEAGE; CELL MATURATION; CELL STRUCTURE; CELLULAR DISTRIBUTION; DENDRITIC CELL; GENE CONTROL; GENE EXPRESSION; GENE REARRANGEMENT; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HOMEOSTASIS; LYMPHOID CELL; MYELOID PROGENITOR CELL; NONHUMAN; REVIEW; SPLEEN CELL;

ANIMALS; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CYTOKINES; DENDRITIC CELLS; HEMATOPOIESIS; MICE;

MURINAE;

EID: 29144508070     PISSN: 08189641     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1711.2005.01390.x     Document Type: Review

References (95)

1. Lian ZX, Okada T, He XS et al. Heterogeneity of dendritic cells in the mouse liver: identification and characterization of four distinct populations. J. Immunol. 2003; 170: 2323-30.
2. Okada T, Lian ZX, Naiki M, Ansari AA, Ikehara S, Gershwin ME. Murine thymic plasmacytoid dendritic cells. Eur. J. Immunol. 2003; 33: 1012-1019.
3. O'Keeffe M, Hochrein H, Vremec D et al. Mouse plasmacytoid cells: long-lived cells, heterogeneous in surface phenotype and function, that differentiate into CD8(+) dendritic cells only after microbial stimulus. J. Exp. Med. 2002; 196: 1307-319.
4. O'Keeffe M, Hochrein H, Vremec D et al. Dendritic cell precursor populations of mouse blood: identification of the murine homologues of human blood plasmacytoid pre-DC2 and CD11c+ DC1 precursors. Blood 2003; 101: 1453-9.
5. Martin P, Ruiz SR, del Hoyo GM et al. Dramatic increase in lymph node dendritic cell number during infection by the mouse mammary tumor virus occurs by a CD62L-dependent blood-borne DC recruitment. Blood 2002; 99: 1282-8.
6. Nakano H, Yanagita M, Gunn MD. CD11c(+)B220(+)Gr-1(+) cells in mouse lymph nodes and spleen display characteristics of plasmacytoid dendritic cells. J. Exp. Med. 2001; 194: 1171-8.
7. Asselin-Paturel C, Boonstra A, Dalod M et al. Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology. Nat. Immunol. 2001; 2: 1144-50.
8. Nikolic T, Dingjan GM, Leenen PJ, Hendriks RW. A subfraction of B220(+) cells in murine bone marrow and spleen does not belong to the B cell lineage but has dendritic cell characteristics. Eur. J. Immunol. 2002; 32: 686-92.
9. Siegal FP, Kadowaki N, Shodell M et al. The nature of the principal type 1 interferon-producing cells in human blood. Science 1999; 284: 1835-7.
10. Bjorck P. Isolation and characterization of plasmacytoid dendritic cells from Flt3 ligand and granulocyte-macrophage colony-stimulating factor-treated mice. Blood 2001; 98: 3520-26.
11. Jarrossay D, Napolitani G, Colonna M, Sallusto F, Lanzavecchia A. Specialization and complementarity in microbial molecule recognition by human myeloid and plasmacytoid dendritic cells. Eur. J. Immunol. 2001; 31: 3388-93.
12. Kadowaki N, Ho S, Antonenko S et al. Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J. Exp. Med. 2001; 194: 863-9.
13. Krug A, Towarowski A, Britsch S et al. Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12. Eur. J. Immunol. 2001; 31: 3026-37.
14. Diebold SS, Kaisho T, Hemmi H, Akira S, Reis e Sousa C. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 2004; 303: 1529-31.
15. Proietto AI, O'Keeffe M, Gartlan K et al. Differential production of inflammatory chemokines by murine dendritic cell subsets. Immunobiology 2004; 209: 163-72.
16. Grouard G, Rissoan MC, Filgueira L, Durand I, Banchereau J, Liu YJ. The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin (IL)-3 and CD40-ligand. J. Exp. Med. 1997; 185: 1101-111.
17. Martin P, Del Hoyo GM, Anjuere F et al. Characterization of a new subpopulation of mouse CD8alpha+ B220+ dendritic cells endowed with type 1 interferon production capacity and tolerogenic potential. Blood 2002; 100: 383-90.
18. Moseman EA, Liang X, Dawson AJ et al. Human plasmacytoid dendritic cells activated by CpG oligodeoxynucleotides induce the generation of CD4+CD25+ regulatory T cells. J. Immunol. 2004; 173: 4433-42.
19. Jego G, Palucka AK, Blanck JP, Chalouni C, Pascual V, Banchereau J. Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6. Immunity 2003; 19: 225-34.
20. Gerosa F, Gobbi A, Zorzi P et al. The reciprocal interaction of NK cells with plasmacytoid or myeloid dendritic cells profoundly affects innate resistance functions. J. Immunol. 2005; 174: 727-34.
21. Dalod M, Hamilton T, Salomon R et al. Dendritic cell responses to early murine cytomegalovirus infection: subset functional specialization and differential regulation by interferon alpha/beta. J. Exp. Med. 2003; 197: 885-98.
22. Colonna M, Krug A, Cella M. Interferon-producing cells: on the front line in immune responses against pathogens. Curr. Opin. Immunol. 2002; 14: 373-9.
23. Hochrein H, O'Keeffe M, Wagner H. Human and mouse plasmacytoid dendritic cells. Hum. Immunol 2002; 63: 1103-110.
24. Liu YJ. IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu. Rev. Immunol. 2005; 23: 275-306.
25. Shortman K, Liu YJ. Mouse and human dendritic cell subtypes. Nat. Rev. Immunol. 2002; 2: 151-61.
26. Vremec D, Zorbas M, Scollay R et al. The surface phenotype of dendritic cells purified from mouse thymus and spleen: investigation of the CD8 expression by a subpopulation of dendritic cells. J. Exp. Med. 1992; 176: 47-58.
27. Vremec D, Shortman K. Dendritic cell subtypes in mouse lymphoid organs: cross-correlation of surface markers, changes with incubation, and differences among thymus, spleen, and lymph nodes. J. Immunol. 1997; 159: 565-73.
28. Vremec D, Pooley J, Hochrein H, Wu L, Shortman K. CD4 and CD8 expression by dendritic cell subtypes in mouse thymus and spleen. J. Immunol. 2000; 164: 2978-86.
29. Wilson NS, El-Sukkari D, Belz GT et al. Most lymphoid organ dendritic cell types are phenotypically and functionally immature. Blood 2003; 102: 2187-94.
30. Henri S, Vremec D, Kamath A et al. The dendritic cell populations of mouse lymph nodes. J. Immunol. 2001; 167: 741-8.
31. Kamath AT, Pooley J, O'Keeffe MA et al. The development, maturation, and turnover rate of mouse spleen dendritic cell populations. J. Immunol. 2000; 165: 6762-70.
32. Kabashima K, Banks TA, Ansel KM, Lu TT, Ware CF, Cyster JG. Intrinsic lymphotoxin-beta receptor requirement for homeostasis of lymphoid tissue dendritic cells. Immunity 2005; 22: 439-50.
33. Naik S, Vremec D, Wu L, O'Keeffe M, Shortman K. CD8alpha+ mouse spleen dendritic cells do not originate from the CD8alpha- dendritic cell subset. Blood 2003; 102: 601-604.
34. Wilson HL, Ni K, O'Neill HC. Identification of progenitor cells in long-term spleen stromal cultures that produce immature dendritic cells. Proc. Natl Acad. Sci. USA 2000; 97: 4784-9.
35. Merad M, Manz MG, Karsunky H et al. Langerhans cells renew in the skin throughout life under steady-state conditions. Nat. Immunol. 2002; 3: 1135-41.
36. Penna G, Sozzani S, Adorini L. Cutting edge: selective usage of chemokine receptors by plasmacytoid dendritic cells. J. Immunol. 2001; 167: 1862-6.
37. Yoneyama H, Matsuno K, Zhang Y et al. Evidence for recruitment of plasmacytoid dendritic cell precursors to inflamed lymph nodes through high endothelial venules. Int. Immunol. 2004; 16: 915-28.
38. Pelayo R, Hirose J, Huang J et al. Derivation of 2 categories of plasmacytoid dendritic cells in murine bone marrow. Blood 2005; 105: 4407-415.
39. Diao J, Winter E, Chen W, Cantin C, Cattral MS. Characterization of distinct conventional and plasmacytoid dendritic cell-committed precursors in murine bone marrow. J. Immunol. 2004; 173: 1826-33.
40. Kamogawa-Schifter Y, Ohkawa J, Namiki S, Arai N, Arai K, Liu Y. Ly49Q defines 2 pDC subsets in mice. Blood 2005; 105: 2787-92.
41. Omatsu Y, Iyoda T, Kimura Y et al. Development of murine plasmacytoid dendritic cells defined by increased expression of an inhibitory NK receptor, Ly49Q. J. Immunol. 2005; 174: 6657-62.
42. Toyama-Sorimachi N, Omatsu Y, Onoda A et al. Inhibitory NK receptor Ly49Q is expressed on subsets of dendritic cells in a cellular maturation- and cytokine stimulation-dependent manner. J. Immunol. 2005; 174: 4621-9.
43. Rasko JE, Metcalf D, Rossner MT, Begley CG, Nicola NA. The flt3/flk-2 ligand: receptor distribution and action on murine haemopoietic cell survival and proliferation. Leukemia 1995; 9: 2058-66.
44. Mackarehtschian K, Hardin JD, Moore KA, Boast S, Goff SP, Lemischka IR. Targeted disruption of the flk2/flt3 gene leads to deficiencies in primitive hematopoietic progenitors. Immunity 1995; 3: 147-61.
45. Sitnicka E, Bryder D, Theilgaard-Monch K, Buza-Vidas N, Adolfsson J, Jacobsen SE. Key role of flt3 ligand in regulation of the common lymphoid progenitor but not in maintenance of the hematopoietic stem cell pool. Immunity 2002; 17: 463-72.
46. Brawand P, Fitzpatrick DR, Greenfield BW, Brasel K, Maliszewski CR, De Smedt T. Murine plasmacytoid pre-dendritic cells generated from Flt3 ligand-supplemented bone marrow cultures are immature APCs. J. Immunol. 2002; 169: 6711-19.
47. McKenna HJ, Stocking KL, Miller RE et al. Mice lacking flt3 ligand have deficient hematopoiesis affecting hematopoietic progenitor cells, dendritic cells, and natural killer cells. Blood 2000; 95: 3489-97.
48. Pulendran B, Banchereau J, Burkeholder S et al. Flt3-ligand and granulocyte colony-stimulating factor mobilize distinct human dendritic cell subsets in vivo. J. Immunol. 2000; 165: 566-72.
49. Suzuki S, Honma K, Matsuyama T et al. Critical roles of interferon regulatory factor 4 in CD11bhighCD8alpha- dendritic cell development. Proc. Natl Acad. Sci. USA 2004; 101: 8981-6.
50. Naik SH, Proietto AI, Wilson NS et al. Cutting edge: Generation of splenic CD8+ and CD8- dendritic cell equivalents in fms-like tyrosine kinase 3 ligand bone marrow cultures. J. Immunol. 2005; 174: 6592-7.
51. Brasel K, De Smedt T, Smith JL, Maliszewski CR. Generation of murine dendritic cells from flt3-ligand-supplemented bone marrow cultures. Blood 2000; 96: 3029-39.
52. Yasuda K, Yu P, Kirschning CJ et al. Endosomal translocation of vertebrate DNA activates dendritic cells via TLR9-dependent and -independent pathways. J. Immunol. 2005; 174: 6129-36.
53. Hemmi H, Kaisho T, Takeda K, Akira S. The roles of Toll-like receptor 9, MyD88, and DNA-dependent protein kinase catalytic subunit in the effects of two distinct CpG DNAs on dendritic cell subsets. J. Immunol. 2003; 170: 3059-64.
54. Sester DP, Naik S, Beasley SJ, Hume DA, Stacey KJ. Phosphorothioate backbone modification modulates macrophage activation by CpG DNA. J. Immunol. 2000; 165: 4165-73.
55. Roberts TL, Sweet MJ, Hume DA, Stacey KJ. Cutting edge: species-specific TLR9-mediated recognition of CpG and non-CpG phosphorothioate-modified oligonucleotides. J. Immunol. 2005; 174: 605-608.
56. Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J. Exp. Med. 1994; 179: 1109-118.
57. Gilliet M, Boonstra A, Paturel C et al. The development of murine plasmacytoid dendritic cell precursors is differentially regulated by FLT3-ligand and granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 2002; 195: 953-8.
58. Kared H, Masson A, Adle-Biassette H, Bach JF, Chatenoud L, Zavala F. Treatment with granulocyte colony-stimulating factor prevents diabetes in NOD mice by recruiting plasmacytoid dendritic cells and functional CD4(+)CD25(+) regulatory T-cells. Diabetes 2005; 54: 78-84.
59. Koopman G, Niphuis H, Haaksma AG et al. Increase in plasmacytoid and myeloid dendritic cells by progenipoietin-1, a chimeric Flt-3 and G-CSF receptor agonist, in SIV-Infected rhesus macaques. Hum. Immunol. 2004; 65: 303-316.
60. Chen W, Antonenko S, Sederstrom JM et al. Thrombopoietin cooperates with FLT3-ligand in the generation of plasmacytoid dendritic cell precursors from human hematopoietic progenitors. Blood 2004; 103: 2547-53.
61. Hirano T. Interleukin 6 and its receptor: ten years later. Int. Rev. Immunol. 1998; 16: 249-84.
62. Park SJ, Nakagawa T, Kitamura H et al. IL-6 regulates in vivo dendritic cell differentiation through STAT3 activation. J. Immunol. 2004; 173: 3844-54.
63. Laouar Y, Weite T, Fu XY, Flavell RA. STAT3 is required for Flt3L-dependent dendritic cell differentiation. Immunity 2003; 19: 903-912.
64. Dakic A, Shao QX, D'Amico A et al. Development of the dendritic cell system during mouse ontogeny. J. Immunol. 2004; 172: 1018-1027.
65. Shigematsu H, Reizis B, Iwasaki H et al. Plasmacytoid dendritic cells activate lymphoid-specific genetic programs irrespective of their cellular origin. Immunity 2004; 21: 43-53.
66. D'Amico A, Wu L. The early progenitors of mouse dendritic cells and plasmacytoid predendritic cells are within the bone marrow hemopoietic precursors expressing Flt3. J. Exp. Med. 2003; 198: 293-303.
67. Akashi K, Traver D, Miyamoto T, Weissman IL. A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature 2000; 404: 193-7.
68. Karsunky H, Merad M, Cozzio A, Weissman IL, Manz MG. Flt3 ligand regulates dendritic cell development from Flt3+ lymphoid and myeloid-committed progenitors to Flt3+ dendritic cells in vivo. J. Exp. Med. 2003; 198: 305-313.
69. Bendriss-Vermare N, Barthelemy C, Durand I et al. Human thymus contains IFN-alpha-producing CD11c(-), myeloid CD11c(+), and mature interdigitating dendritic cells. J. Clin. Invest. 2001; 107: 835-44.
70. Corcoran L, Ferrero I, Vremec D et al. The lymphoid past of mouse plasmacytoid cells and thymic dendritic cells. J. Immunol. 2003; 170: 4926-32.
71. Res PC, Couwenberg F, Vyth-Dreese FA, Spits H. Expression of pTα mRNA in a committed dendritic cell precursor in the human thymus. Blood 1999; 94: 2647-57.
72. Wang YH, Liu YJ. Mysterious origin of plasmacytoid dendritic cell precursors. Immunity 2004; 21: 1-5.
73. Blom B, Ho S, Antonenko S, Liu YJ. Generation of interferon alpha-producing predendritic cell (Pre-DC)2 from human CD34(+) hematopoietic stem cells. J. Exp. Med. 2000; 192: 1785-96.
74. Weijer K, Uittenbogaart CH, Voordouw A et al. Intrathymic and extrathymic development of human plasmacytoid dendritic cell precursors in vivo. Blood 2002; 99: 2752-9.
75. Rissoan MC, Duhen T, Bridon JM et al. Subtractive hybridization reveals the expression of immunoglobulin-like transcript 7, Eph-B1, granzyme B, and 3 novel transcripts in human plasmacytoid dendritic cells. Blood 2002; 100: 3295-303.
76. Nutt SL, Metcalf D, D'Amico A, Polli M, Wu L. Dynamic regulation of PU.1 expression in multipotent hematopoietic progenitors. J. Exp. Med. 2005; 201: 221-31.
77. Tamura T, Tailor P, Yamaoka K et al. IFN regulatory factor-4 and -8 govern dendritic cell subset development and their functional diversity. J. Immunol. 2005; 174: 2573-81.
78. Schotte R, Rissoan MC, Bendriss-Vermare N et al. The transcription factor Spi-B is expressed in plasmacytoid DC precursors and inhibits T-, B-, and NK-cell development. Blood 2003; 101: 1015-1023.
79. Schotte R, Nagasawa M, Weijer K, Spits H, Blom B. The ETS transcription factor Spi-B is required for human plasmacytoid dendritic cell development. J. Exp. Med. 2004; 200: 1503-509.
80. Hacker C, Kirsch RD, Ju XS et al. Transcriptional profiling identifies Id2 function in dendritic cell development. Nat. Immunol. 2003; 4: 380-86.
81. Spits H, Couwenberg F, Bakker AQ, Weijer K, Uittenbogaart CH. Id2 and Id3 inhibit development of CD34(+) stem cells into predendritic cell (pre-DC)2 but not into pre-DC1. Evidence for a lymphoid origin of pre-DC2. J. Exp. Med. 2000; 192: 1775-84.
82. Schiavoni G, Mattei F, Sestili P et al. ICSBP is essential for the development of mouse type I interferon-producing cells and for the generation and activation of CD8alpha(+) dendritic cells. J. Exp. Med. 2002; 196: 1415-25.
83. Schiavoni G, Mattei F, Borghi P et al. ICSBP is critically involved in the normal development and trafficking of Langerhans cells and dermal dendritic cells. Blood 2004; 103: 2221-8.
84. Tsujimura H, Tamura T, Ozato K. Cutting edge: IFN consensus sequence binding protein/IFN regulatory factor 8 drives the development of type I IFN-producing plasmacytoid dendritic cells. J. Immunol. 2003; 170: 1131-5.
85. Aliberti J, Schulz O, Pennington DJ et al. Essential role for ICSBP in the in vivo development of murine CD8alpha + dendritic cells. Blood 2003; 101: 305-310.
86. Adolfsson J, Mansson R, Buza-Vidas N et al. Identification of Flt3+ lympho-myeloid stem cells lacking erythro-megakaryocytic potential: a revised road map for adult blood lineage commitment. Cell 2005; 121: 295-306.
87. Olweus J, BitMansour A, Warnke R et al. Dendritic cell ontogeny: a human dendritic cell lineage of myeloid origin. Proc. Natl Acad. Sci. USA 1997; 94: 12 551-6.
88. Krug A, Rothenfusser S, Hornung V et al. Identification of CpG oligonucleotide sequences with high induction of IFN-alpha/beta in plasmacytoid dendritic cells. Eur. J. Immunol. 2001; 31: 2154-63.
89. Yang GX, Lian ZX, Kikuchi K et al. CD4- plasmacytoid dendritic cells (pDCs) migrate in lymph nodes by CpG inoculation and represent a potent functional subset of pDCs. J. Immunol. 2005; 174: 3197-203.
90. Toyama-Sorimachi N, Tsujimura Y, Maruya M et al. Ly49Q, a member of the Ly49 family that is selectively expressed on myeloid lineage cells and involved in regulation of cytoskeletal architecture. Proc. Natl Acad. Sci. USA 2004; 101: 1016-1021.
91. Zuniga EI, McGavern DB, Pruneda-Paz JL, Teng C, Oldstone MB. Bone marrow plasmacytoid dendritic cells can differentiate into myeloid dendritic cells upon virus infection. Nat. Immunol. 2004; 5: 1227-34.
92. Galibert E, Maliszewski CR, Vandenabeele S. Plasmacytoid monocytes/T cells: a dendritic cell lineage? Semin. Immunol. 2001; 13: 283-9.
93. Feldman S, Stein D, Amrute S et al. Decreased interferon-alpha production in HIV-infected patients correlates with numerical and functional deficiencies in circulating type 2 dendritic cell precursors. Clin. Immunol 2001; 101: 201-210.
94. Dalloul A, Oksenhendler E, Chosidow O et al. Severe herpes virus (HSV-2) infection in two patients with myelodysplasia and undetectable NK cells and plasmacytoid dendritic cells in the blood. J. Clin. Virol. 2004; 30: 329-36.
95. Pacanowski J, Kahi S, Baillet M et al. Reduced blood CD123+ (lymphoid) and CD11c+ (myeloid) dendritic cell numbers in primary HIV-1 infection. Blood 2001; 98: 3016-3021.